Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure

Background Understanding how nanomaterials are distributed in the body after exposure is important for assessing whether they are safe. In this study, we investigated the behavior and accumulation of nanoscaled and submicron-scaled zinc oxide (ZnO) particles in the body using optical imaging following oral exposure. Methods To trace these nanoparticles in the body, ZnO nanoparticles were conjugated with a monoreactive hydroxysuccinimide ester of Cy5.5 (Cy5.5-NHS), and the conjugation-stabilizing effect of Cy5.5 on the nanoparticles was evaluated in simulated gastric fluid (pH 1.2) for 7 hours. To compare the distribution of Cy5.5-NHS and Cy5.5-conjugated ZnO nanoparticles, Cy5.5-NHS 0.5 mg/kg and Cy5.5-conjugated ZnO nanoparticles 250 mg/kg were administered orally to healthy rats. We collected blood from the rats at predesignated time points for 7 hours after administration, and optical imaging studies were performed at 1, 2, 3, 5, and 7 hours after dosing. To investigate the extent of nanoparticle accumulation in the organs and tissues, the mice were sacrificed at 23 hours after administration, and the organs were removed and imaged. Results Cy5.5-conjugated ZnO nanoparticles were stable in simulated gastric fluid for 7 hours. The signal intensity of Cy5.5-NHS in blood was highest 3 hours after oral administration, and Cy5.5-conjugated ZnO nanoparticles showed the highest signal intensity in blood 5–7 hours after administration. In vivo optical images indicated that Cy5.5-NHS showed optical signals in the lung, liver, and gastrointestinal tract after oral administration, whereas Cy5.5-conjugated ZnO nanoparticles were seen only in the gastrointestinal tract. Seven hours following administration, biodistribution studies demonstrated that Cy5.5-NHS accumulated in the lung and liver, and Cy5.5-conjugated ZnO nanoparticles resulted in a strong signal in the kidney and liver. Different-sized ZnO nanoparticles showed dissimilar patterns of biodistribution in ex vivo optical images. Conclusion ZnO nanoparticles are absorbed into the tissues following oral exposure and their behavior can be monitored and evaluated using optical imaging.

[1]  Jesse V Jokerst,et al.  Molecular imaging with theranostic nanoparticles. , 2011, Accounts of chemical research.

[2]  P. Ray,et al.  Multimodality molecular imaging of disease progression in living subjects , 2011, Journal of Biosciences.

[3]  Erlong Zhang,et al.  A review of NIR dyes in cancer targeting and imaging. , 2011, Biomaterials.

[4]  E. Martínez,et al.  Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications , 2010, Expert opinion on drug delivery.

[5]  J. Irache,et al.  Molecular Imaging Techniques to Study the Biodistribution of Orally Administered 99mTc-Labelled Naive and Ligand-Tagged Nanoparticles , 2011, Molecular Imaging and Biology.

[6]  Diana Anderson,et al.  Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2) , 2012, Apoptosis.

[7]  B. Lich,et al.  Imaging methods for determining uptake and toxicity of carbon nanotubes in vitro and in vivo. , 2011, Nanomedicine.

[8]  U. Vogel,et al.  Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate , 2011, Particle and Fibre Toxicology.

[9]  Chung‐Che Wu,et al.  Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice , 2012, Nanotoxicology.

[10]  D. Dhawan,et al.  Effect of zinc on biological half-lives of 65Zn in whole body and liver and on distribution of 65Zn in different organs of rats following nickel toxicity , 2007, Biological Trace Element Research.

[11]  Marc Burghartz,et al.  Repetitive exposure to zinc oxide nanoparticles induces dna damage in human nasal mucosa mini organ cultures , 2011, Environmental and molecular mutagenesis.

[12]  Louis W. Chang,et al.  The use of radioactive zinc oxide nanoparticles in determination of their tissue concentrations following intravenous administration in mice. , 2010, The Analyst.

[13]  S. Ganapathy,et al.  Toxicity of zinc oxide nanoparticles through oral route , 2012, Toxicology and industrial health.

[14]  J Michael Newton,et al.  Gastric emptying of multi-particulate dosage forms. , 2010, International journal of pharmaceutics.

[15]  Yiwei Teow,et al.  Health Impact and Safety of Engineered Nanomaterials , 2011 .

[16]  Dongmei Cun,et al.  Effect of Crystal Size on the In Vitro Dissolution and Oral Absorption of Nitrendipine in Rats , 2010, Pharmaceutical Research.

[17]  W. Banlunara,et al.  An evaluation of acute toxicity of colloidal silver nanoparticles. , 2011, The Journal of veterinary medical science.

[18]  Washington Sanchez,et al.  Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. , 2008, Journal of biomedical optics.

[19]  A. Pandey,et al.  Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. , 2012, Mutation research.

[20]  Michihiro Nakamura,et al.  Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer's patches using fluorescent organosilica particles. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[21]  Andrew Tsourkas,et al.  ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance. , 2012, Biomaterials.

[22]  Thomas R. Tice,et al.  Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .